Cargando…

Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study

BACKGROUND: We aimed to determine whether synovial fluid (SF) biomarkers can predict the progression of articular cartilage damage as determined by arthroscopic evaluation during and after anterior cruciate ligament (ACL) reconstruction. METHODS: Arthroscopic assessment of articular cartilage damage...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobue, Yasumori, Kojima, Toshihisa, Kurokouchi, Kazutoshi, Takahashi, Shigeo, Yoshida, Hiroaki, Poole, Robin, Ishiguro, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718025/
https://www.ncbi.nlm.nih.gov/pubmed/29208010
http://dx.doi.org/10.1186/s13075-017-1471-1
_version_ 1783284267293343744
author Sobue, Yasumori
Kojima, Toshihisa
Kurokouchi, Kazutoshi
Takahashi, Shigeo
Yoshida, Hiroaki
Poole, Robin
Ishiguro, Naoki
author_facet Sobue, Yasumori
Kojima, Toshihisa
Kurokouchi, Kazutoshi
Takahashi, Shigeo
Yoshida, Hiroaki
Poole, Robin
Ishiguro, Naoki
author_sort Sobue, Yasumori
collection PubMed
description BACKGROUND: We aimed to determine whether synovial fluid (SF) biomarkers can predict the progression of articular cartilage damage as determined by arthroscopic evaluation during and after anterior cruciate ligament (ACL) reconstruction. METHODS: Arthroscopic assessment of articular cartilage damage was performed twice in 62 patients, first during ACL reconstruction and then approximately 2 years later during implant removal for ligament fixation. SF levels of the collagenase-generated cleavage neoepitope of type II collagen (C2C) and proteoglycan glycosaminoglycans keratan sulfate (KS), chondroitin-4-sulfate (Δdi-C4S), and chondroitin-6-sulfate (Δdi-C6S) were measured at ACL reconstruction. Associations between baseline biomarker levels and subsequent progression of cartilage damage were determined using receiver operating characteristic analysis and multivariable logistic regression analysis. RESULTS: No radiographic changes were observed in any of the patients. Progression of high-grade cartilage damage, observed arthroscopically, was negatively correlated with levels of Δdi-C6S and KS, as well as the ratio of Δdi-C6S to Δdi-C4S (C6S/C4S). Logistic regression analysis revealed significant associations of Δdi-C6S (cut-off: 55.7 nmol/ml, odds ratio (OR) 0.231, 95% confidence interval (CI) 0.061–0.879), KS (cut-off: 10.6 μg/ml, OR 0.114, 95% CI 0.024–0.529), and C6S/C4S ratio (cut-off: 4.6, OR 0.060, 95% CI 0.005–0.737) with the progression of high-grade cartilage damage after adjusting for age, the duration from injury to first surgery, sex, and the number of high-grade lesions (grades III and IV) at baseline. CONCLUSIONS: The progression of high-grade cartilage damage was significantly associated with baseline levels of proteoglycan glycosaminoglycan biomarkers; namely, Δdi-C6S, KS, and C6S/C4S ratio. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1471-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5718025
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57180252017-12-08 Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study Sobue, Yasumori Kojima, Toshihisa Kurokouchi, Kazutoshi Takahashi, Shigeo Yoshida, Hiroaki Poole, Robin Ishiguro, Naoki Arthritis Res Ther Research Article BACKGROUND: We aimed to determine whether synovial fluid (SF) biomarkers can predict the progression of articular cartilage damage as determined by arthroscopic evaluation during and after anterior cruciate ligament (ACL) reconstruction. METHODS: Arthroscopic assessment of articular cartilage damage was performed twice in 62 patients, first during ACL reconstruction and then approximately 2 years later during implant removal for ligament fixation. SF levels of the collagenase-generated cleavage neoepitope of type II collagen (C2C) and proteoglycan glycosaminoglycans keratan sulfate (KS), chondroitin-4-sulfate (Δdi-C4S), and chondroitin-6-sulfate (Δdi-C6S) were measured at ACL reconstruction. Associations between baseline biomarker levels and subsequent progression of cartilage damage were determined using receiver operating characteristic analysis and multivariable logistic regression analysis. RESULTS: No radiographic changes were observed in any of the patients. Progression of high-grade cartilage damage, observed arthroscopically, was negatively correlated with levels of Δdi-C6S and KS, as well as the ratio of Δdi-C6S to Δdi-C4S (C6S/C4S). Logistic regression analysis revealed significant associations of Δdi-C6S (cut-off: 55.7 nmol/ml, odds ratio (OR) 0.231, 95% confidence interval (CI) 0.061–0.879), KS (cut-off: 10.6 μg/ml, OR 0.114, 95% CI 0.024–0.529), and C6S/C4S ratio (cut-off: 4.6, OR 0.060, 95% CI 0.005–0.737) with the progression of high-grade cartilage damage after adjusting for age, the duration from injury to first surgery, sex, and the number of high-grade lesions (grades III and IV) at baseline. CONCLUSIONS: The progression of high-grade cartilage damage was significantly associated with baseline levels of proteoglycan glycosaminoglycan biomarkers; namely, Δdi-C6S, KS, and C6S/C4S ratio. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1471-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-06 2017 /pmc/articles/PMC5718025/ /pubmed/29208010 http://dx.doi.org/10.1186/s13075-017-1471-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sobue, Yasumori
Kojima, Toshihisa
Kurokouchi, Kazutoshi
Takahashi, Shigeo
Yoshida, Hiroaki
Poole, Robin
Ishiguro, Naoki
Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
title Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
title_full Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
title_fullStr Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
title_full_unstemmed Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
title_short Prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type II collagen biomarkers in a retrospective observational study
title_sort prediction of progression of damage to articular cartilage 2 years after anterior cruciate ligament reconstruction: use of aggrecan and type ii collagen biomarkers in a retrospective observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718025/
https://www.ncbi.nlm.nih.gov/pubmed/29208010
http://dx.doi.org/10.1186/s13075-017-1471-1
work_keys_str_mv AT sobueyasumori predictionofprogressionofdamagetoarticularcartilage2yearsafteranteriorcruciateligamentreconstructionuseofaggrecanandtypeiicollagenbiomarkersinaretrospectiveobservationalstudy
AT kojimatoshihisa predictionofprogressionofdamagetoarticularcartilage2yearsafteranteriorcruciateligamentreconstructionuseofaggrecanandtypeiicollagenbiomarkersinaretrospectiveobservationalstudy
AT kurokouchikazutoshi predictionofprogressionofdamagetoarticularcartilage2yearsafteranteriorcruciateligamentreconstructionuseofaggrecanandtypeiicollagenbiomarkersinaretrospectiveobservationalstudy
AT takahashishigeo predictionofprogressionofdamagetoarticularcartilage2yearsafteranteriorcruciateligamentreconstructionuseofaggrecanandtypeiicollagenbiomarkersinaretrospectiveobservationalstudy
AT yoshidahiroaki predictionofprogressionofdamagetoarticularcartilage2yearsafteranteriorcruciateligamentreconstructionuseofaggrecanandtypeiicollagenbiomarkersinaretrospectiveobservationalstudy
AT poolerobin predictionofprogressionofdamagetoarticularcartilage2yearsafteranteriorcruciateligamentreconstructionuseofaggrecanandtypeiicollagenbiomarkersinaretrospectiveobservationalstudy
AT ishiguronaoki predictionofprogressionofdamagetoarticularcartilage2yearsafteranteriorcruciateligamentreconstructionuseofaggrecanandtypeiicollagenbiomarkersinaretrospectiveobservationalstudy